Sunday, September 13, 2026

Strategy Hikes STRC Dividend to 12%, Authorizes $2B Buyback as mNAV Falls Below 1

Strategy overhauled its capital framework after its market-to-net-asset-value premium dropped below 1, signaling investors no longer trust its leveraged Bitcoin-accumulation model. The company raised its STRC preferred dividend to 12%, authorized a $2 billion buyback, and launched a monetization program, while Bitcoin ETFs shed $4 billion in a month.

LM Salvado
LM Salvado

July 16, 2026

Source Trace Score1 source document1 with a live linkVerifiability: Basic
Strategy Hikes STRC Dividend to 12%, Authorizes $2B Buyback as mNAV Falls Below 1
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.

Strategy's market-to-net-asset-value (mNAV) premium has fallen below 1, the clearest signal yet that investors are pulling back from its leveraged Bitcoin-accumulation model. The company is now restructuring its capital framework in response.

Strategy raised its STRC preferred dividend to 12% to retain capital and hold investors amid the mNAV slide. It also authorized a $2 billion share buyback and launched a monetization program, moving beyond a strategy built solely on accumulating Bitcoin.

Michael Saylor, the company's chairman, sold a small amount of Bitcoin as part of the shift. Bitcoin ETFs recorded $4 billion in outflows over the same month, pointing to a broader cooling in institutional crypto demand beyond Strategy alone.

Regulators are moving in parallel. The Bank for International Settlements' annual report cast doubt on stablecoins' status as money, arguing they function more like exchange-traded fund shares than a means of payment.1 The BIS said stablecoins "trade off par" and show "redemption frictions... which we've literally never seen," and that they "don't settle on central bank balance sheets and can't guarantee par across issuers."1

The BIS also warned that dollar-denominated stablecoins are accelerating dollarization in fragile economies, weakening local currencies and undermining capital controls. "You can't enforce border rules on a self-custodied token," the institution said.1

The timing links two threads in crypto-adjacent finance: corporate Bitcoin treasuries built on leverage and premium valuation are showing their first real strain, while global regulators signal tighter scrutiny of the stablecoin infrastructure underpinning much of the crypto market. For Strategy, the capital framework overhaul marks a departure from its identity as a pure Bitcoin-accumulation vehicle toward one that also manages shareholder returns directly through dividends and buybacks.

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score1 source document1 with a live linkVerifiability: Basic
  1. [1]News articleYahoo Finance· June 29, 2026
    Saylor's Strategy changes playbook and can now sell its bitcoin

In this story · Knowledge Files

LM Salvado
LM Salvado

LM Salvado is an AI possibilist — he takes the risks of AI seriously, and still sees the route through them. Founder of Via News Network, an AI-native newsroom built on full source-traceability, he tracks how AI is reshaping markets, capital, and labor — the quiet shifts that happen before the headlines catch up.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Keeps Flowing as Enterprise Adoption and Government Contracts Validate the Bet
A late-August surge of nine-figure funding rounds (Socure, Stability AI, Generalist AI, Gatik, Regent Craft, Emerald AI, Owner) shows venture capital still pouring into AI infrastructure, identity/fintech, and autonomy, even as public-market sentiment stays jumpy — Palantir's stock fell 6% the same week it landed the Army's TITAN contract. UiPath's raised guidance and strong Q2 results, alongside efficiency breakthroughs like Multiverse Computing's model compression, point to real enterprise monetization catching up to the funding hype.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
JPMorgan Chase & Co.
Both facts record the same attribute (net_income) for JPMorgan Chase & Co. in the identical fiscal period (Q1 2026) and observation date (2026-03-31), but report values that differ by approximately 1 billion times: $16,494,000,000 vs $16.49. These cannot both be true simultaneously. The discrepancy suggests either a unit mismatch (e.g., one is total net income, the other earnings per share mislabeled as net_income), a decimal point error, or data entry corruption. For the same entity, attribute, and time period, only one value can be correct.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,280 source documents archived
Query this data → isubstrate.com